{"links": [{"source": 0, "target": "t6018", "value": "None"}, {"source": 0, "target": "t6008", "value": "None"}, {"source": "t6018", "target": "t6024", "value": "None"}, {"source": "t6018", "target": "t6025", "value": "None"}, {"source": "t6018", "target": "t6023", "value": "None"}, {"source": "t6018", "target": "t6019", "value": "None"}, {"source": "t6008", "target": "t6017", "value": "None"}, {"source": "t6008", "target": "t6009", "value": "None"}, {"source": "t6019", "target": "t6020", "value": "None"}, {"source": "t6009", "target": "t6014", "value": "None"}, {"source": "t6009", "target": "t6010", "value": "None"}, {"source": "t6009", "target": "t6013", "value": "None"}, {"source": "t6009", "target": "t6012", "value": "None"}, {"source": "t6009", "target": "t6011", "value": "None"}, {"source": "t6020", "target": "t6021", "value": "None"}, {"source": "t6014", "target": "t6015", "value": "None"}, {"source": "t6010", "target": "t6015", "value": "None"}, {"source": "t6013", "target": "t6015", "value": "None"}, {"source": "t6012", "target": "t6015", "value": "None"}, {"source": "t6011", "target": "t6015", "value": "None"}, {"source": "t6021", "target": "t6022", "value": "None"}, {"source": "t6015", "target": "t6016", "value": "None"}], "nodes": [{"category": "disease", "id": 0, "name": "HIV_and_AIDS", "x": "100", "y": "50", "fixed": "true", "draggable": "true", "value": {"name": "HIV_and_AIDS"}}, {"category": "treatment", "id": "t6018", "name": "person at risk of hiv", "draggable": "true", "value": {"name": "person at risk of hiv", "type": "information and support", "time": "", "intention": "", "description": "title:person at risk of hiv", "drug": {}}}, {"category": "treatment", "id": "t6008", "name": "person who may have undiagnosed hiv", "draggable": "true", "value": {"name": "person who may have undiagnosed hiv", "type": "information and support", "time": "", "intention": "", "description": "title:person who may have undiagnosed hiv", "drug": {}}}, {"category": "treatment", "id": "t6024", "name": "preventing stis and under18 conceptions", "draggable": "true", "value": {"name": "preventing stis and under18 conceptions", "type": "treatment related", "time": "", "intention": "", "description": "title:preventing stis and under18 conceptions", "drug": {}}}, {"category": "treatment", "id": "t6025", "name": "patient experience", "draggable": "true", "value": {"name": "patient experience", "type": "treatment related", "time": "", "intention": "", "description": "title:patient experience", "drug": {}}}, {"category": "treatment", "id": "t6023", "name": "needle and syringe programmes", "draggable": "true", "value": {"name": "needle and syringe programmes", "type": "information and support", "time": "", "intention": "", "description": "title:needle and syringe programmes", "drug": {}}}, {"category": "treatment", "id": "t6019", "name": "establish local prevalence", "draggable": "true", "value": {"name": "establish local prevalence", "type": "information and support", "time": "", "intention": "", "description": "title:establish local prevalencehead:Establish local prevalenceOffer and recommend HIV testing based on local prevalence and how it affects different groups and communities. Use Public Health England s sexual and reproductive health profiles and local data to establish: local HIV prevalence, including whether an area has high prevalence or extremely high prevalence rates of HIV in different groups and communities.SourcesThe NICE guidance that was used to create this part of the interactive flowchart. NG60", "drug": {}}}, {"category": "treatment", "id": "t6017", "name": "staff knowledge and values", "draggable": "true", "value": {"name": "staff knowledge and values", "type": "information and support", "time": "", "intention": "", "description": "title:staff knowledge and valueshead:Staff knowledge and valuesStaff offering HIV tests should: Emphasise that the tests are confidential. If people remain concerned about confidentiality, explain that they can visit a sexual health clinic anonymously. Be able to discuss HIV symptoms and the implications of a positive or a negative test.  Be familiar with existing referral pathways so that people who test positive receive prompt and appropriate support. Provide appropriate information to people who test negative, including details of where to get free condoms and how to access local behavioural and preventive interventions.  Recognise and be sensitive to the cultural issues facing different groups (for example, some groups or communities may be less used to preventive health services and advice, or may fear isolation and social exclusion if they test positive for HIV).  Be able to challenge stigmas and dispel misconceptions surrounding HIV and HIV testing and be sensitive to people s needs. Be able to recognise the symptoms that may signify primary HIV infection or illnesses that often coexist with HIV. In such cases, they should be able to offer and recommend an HIV test.SourcesThe NICE guidance that was used to create this part of the interactive flowchart. NG60", "drug": {}}}, {"category": "treatment", "id": "t6009", "name": "offer tests in different settings", "draggable": "true", "value": {"name": "offer tests in different settings", "type": "treatment related", "time": "", "intention": "", "description": "title:offer tests in different settings", "drug": {}}}, {"category": "treatment", "id": "t6020", "name": "promoting awareness and uptake of hiv testing", "draggable": "true", "value": {"name": "promoting awareness and uptake of hiv testing", "type": "information and support", "time": "", "intention": "", "description": "title:promoting awareness and uptake of hiv testinghead:Promoting awareness and uptake of HIV testingsubhead:Methods of raising awarenessUse or modify existing resources, for example TV screens in GP surgeries, to help raise awareness of where HIV testing (including self-sampling) is available (see also  Content of health promotion materials  below).Consider a range of approaches to promote HIV testing, including: local media campaigns digital media, such as educational videos social media, such as online social networking, dating and geospatial apps printed materials, such as information leaflets.Ensure interventions to increase the uptake of HIV testing are hosted by, or advertised at, venues that encourage or facilitate sex (such as some saunas, websites, or geospatial apps that allow people to find sexual partners in their proximity). This should be in addition to general community-based HIV health promotion.Promote HIV testing when delivering sexual health promotion and HIV prevention interventions. This can be carried out in person (using printed publications such as leaflets, booklets and posters) or through electronic media.Advertise HIV testing in settings that offer it (for example, using posters in GP surgeries) and make people aware that healthcare professionals welcome the opportunity to discuss HIV testing.See what NICE says on community engagement.subhead:Content of health promotion materialsMaterials and interventions for promoting awareness and increasing the uptake of HIV testing should be designed in line with NICE s recommendations on behaviour change and patient experience.Provide promotional material tailored to the needs of local communities. It should: provide information about HIV infection and transmission, the benefits of HIV testing and the availability of treatment  emphasise that early diagnosis is not only a route into treatment and a way to avoid complications and reduce serious illness in the future, but also reduces onward transmission detail how and where to access local HIV testing services, including services offering POCT and self-sampling, and sexual health clinics dispel common misconceptions about HIV diagnosis and treatment present testing as a responsible act by focusing on trigger points, such as the beginning of a new relationship or change of sexual partner, or on the benefits of knowing one s HIV status address the needs of non-English-speaking groups, for example, through translated and culturally sensitive information.Ensure health promotion material aims to reduce the stigma associated with HIV testing and living with HIV, both among communities and among healthcare professionals.Ensure health promotion material provides up-to-date information on the different kinds of HIV tests available. It should also highlight the significantly reduced window period resulting from the introduction of newer tests such as fourth generation serological testing.For further information on POCT and self-sampling, see point of care testing and self-sampling.SourcesThe NICE guidance that was used to create this part of the interactive flowchart. NG60", "drug": {}}}, {"category": "treatment", "id": "t6014", "name": "specialist sexual health services", "draggable": "true", "value": {"name": "specialist sexual health services", "type": "information and support", "time": "", "intention": "", "description": "title:specialist sexual health serviceshead:Specialist sexual health servicesOffer and recommend an HIV test to everyone who attends for testing or treatment.Ensure both fourth generation serological testing and POCT are available.Quality standardsThe following quality statement is relevant to this part of the interactive flowchart.3HIV indicator conditionsSourcesThe NICE guidance that was used to create this part of the interactive flowchart. NG60", "drug": {}}}, {"category": "treatment", "id": "t6010", "name": "community settings", "draggable": "true", "value": {"name": "community settings", "type": "information and support", "time": "", "intention": "", "description": "title:community settingshead:Community settingsProviders of community testing services (including outreach and detached services) should set up testing services in: areas with a high prevalence or extremely high prevalence of HIV, using venues such as pharmacies or voluntary sector premises (for example, those of faith groups) venues where there may be high-risk sexual behaviour, for example, public sex environments, or where people at high risk may gather, such as nightclubs, saunas and festivals.Recognise that not all community settings are appropriate for providing testing services, for example because tests should be undertaken in a secluded or private area (in line with British HIV Association guidelines).Ensure that people who decline or are unable to consent to a test are offered information about other local testing services, including self-sampling. See making decisions using NICE guidelines for more information about consent.Ensure that lay testers delivering tests are competent to do so and have access to clinical advice and supervision.SourcesThe NICE guidance that was used to create this part of the interactive flowchart. NG60", "drug": {}}}, {"category": "treatment", "id": "t6013", "name": "secondary and emergency care", "draggable": "true", "value": {"name": "secondary and emergency care", "type": "treatment related", "time": "", "intention": "", "description": "title:secondary and emergency carehead:Secondary and emergency careRoutinely offer and recommend an HIV test to everyone attending their first appointment (followed by repeat testing in line with the guidance on repeat testing) at drug dependency programmes, termination of pregnancy servicesAntenatal HIV testing is covered by the UK National Screening Committee and is outside the remit of this interactive flowchart., and services providing treatment for: hepatitis B  hepatitis C  lymphoma  tuberculosis.In all areas, offer and recommend HIV testing on admission to hospital, including emergency departments, to everyone who has not previously been diagnosed with HIV and who: has symptoms that may indicate HIV or HIV is part of the differential diagnosis (for example, infectious mononucleosis-like syndrome), in line with HIV in Europe s HIV in indicator conditions is known to be from a country or group with a high rate of infection (see establish local prevalence) if male, discloses that they have sex with men, or is known to have sex with men and has not had an HIV test in the previous year is a trans woman who has sex with men and has not had an HIV test in the previous year  reports sexual contact (either abroad or in the UK) with someone from a country with a high rate of HIV discloses high-risk sexual practices, for example the practice known as chemsex is diagnosed with, or requests testing for, a sexually transmitted infection reports a history of injecting drug use discloses that they are the sexual partner of someone known to be HIV positive, or of someone at high risk of HIV (for example, female sexual contacts of men who have sex with men).In areas of high and extremely high prevalence, also offer and recommend HIV testing on admission to hospital, including emergency departments, to everyone who has not previously been diagnosed with HIV and who is undergoing blood tests for another reason.Additionally, in areas of extremely high prevalence, offer and recommend HIV testing on admission to hospital, including emergency departments, to everyone who has not previously been diagnosed with HIV.Quality standardsThe following quality statements are relevant to this part of the interactive flowchart.1Hospitals in areas of high and extremely high HIV prevalence3HIV indicator conditionsSourcesThe NICE guidance that was used to create this part of the interactive flowchart. NG60", "drug": {}}}, {"category": "treatment", "id": "t6012", "name": "prisons", "draggable": "true", "value": {"name": "prisons", "type": "information and support", "time": "", "intention": "", "description": "title:prisonshead:PrisonsAt reception, recommend HIV testing to everyone who has not previously been diagnosed with HIV. For more information see NICE s recommendations on health of people in the criminal justice system.SourcesThe NICE guidance that was used to create this part of the interactive flowchart. NG60", "drug": {}}}, {"category": "treatment", "id": "t6011", "name": "gp surgeries", "draggable": "true", "value": {"name": "gp surgeries", "type": "treatment related", "time": "", "intention": "", "description": "title:gp surgerieshead:GP surgeriesIn all areas, offer and recommend HIV testing to everyone who has not previously been diagnosed with HIV and who: has symptoms that may indicate HIV or HIV is part of the differential diagnosis (for example, infectious mononucleosis-like syndrome), in line with HIV in Europe s HIV in indicator conditions is known to be from a country or group with a high rate of HIV infection (see establish local prevalence) if male, discloses that they have sex with men, or is known to have sex with men, and has not had an HIV test in the previous year  is a trans woman who has sex with men and has not had an HIV test in the previous year  reports sexual contact (either abroad or in the UK) with someone from a country with a high rate of HIV  discloses high-risk sexual practices, for example the practice known as chemsex  is diagnosed with, or requests testing for, a sexually transmitted infection reports a history of injecting drug use  discloses that they are the sexual partner of someone known to be HIV positive, or of someone at high risk of HIV (for example, female sexual contacts of men who have sex with men).In areas of high and extremely high prevalence, also offer and recommend HIV testing to everyone who has not previously been diagnosed with HIV and who: registers with the practice or is undergoing blood tests for another reason and has not had an HIV test in the previous year.Additionally, in areas of extremely high prevalence, consider HIV testing opportunistically at each consultation (whether bloods are being taken for another reason or not), based on clinical judgement.Offer and recommend repeat testing to the people identified above in line with the guidance on repeat testing.If a venous blood sample is declined, offer a less invasive form of specimen collection, such as a mouth swab or finger-prick.Quality standardsThe following quality statements are relevant to this part of the interactive flowchart.2General practice in areas of high and extremely high HIV prevalence3HIV indicator conditionsSourcesThe NICE guidance that was used to create this part of the interactive flowchart. NG60", "drug": {}}}, {"category": "treatment", "id": "t6021", "name": "plan referral routes", "draggable": "true", "value": {"name": "plan referral routes", "type": "information and support", "time": "", "intention": "", "description": "title:plan referral routeshead:Plan referral routesEnsure practitioners delivering HIV tests (including those delivering outreach POCT) have clear referral pathways available for people with both positive and negative test results, including to sexual health services, behavioural and health promotion services, HIV services and confirmatory serological testing, if needed. These pathways should ensure the following: People who test positive are seen by an HIV specialist preferably within 48 hours, certainly within 2 weeks of receiving the result (in line with UK national guidelines for HIV testing 2008). They should also be given information about their diagnosis and local support groups. Practitioners in the voluntary or statutory sector can refer people from HIV prevention and health promotion services into services that offer HIV testing and vice versa.SourcesThe NICE guidance that was used to create this part of the interactive flowchart. NG60", "drug": {}}}, {"category": "treatment", "id": "t6015", "name": "principles of hiv testing", "draggable": "true", "value": {"name": "principles of hiv testing", "type": "information and support", "time": "", "intention": "", "description": "title:principles of hiv testinghead:Principles of HIV testingStaff offering HIV tests should: Emphasise that the tests are confidential. If people remain concerned about confidentiality, explain that they can visit a sexual health clinic anonymously. Provide appropriate information to people who test negative, including details of where to get free condoms and how to access local behavioural and preventive interventions.subhead:Recommending repeat testsWhen giving results to people who have tested negative but who may have been exposed to HIV recently, recommend that they have another test once they are past the window period.Recommend annual testing to people in groups or communities with a high rate of HIV, and more frequently if they are at high risk of exposure (in line with Public Health England s HIV in the UK: situation report 2015). For example: men who have sex with men should have HIV and sexually transmitted infection tests at least annually, and every 3 months if they are having unprotected sex with new or casual partners black African men and women should have an HIV test and regular HIV and sexually transmitted infection tests if having unprotected sex with new or casual partners.Consider the following interventions to promote repeat testing: Call\u2013recall methods using letters or other media, such as text messages or email, to remind people to return for annual testing. Electronic reminders in health records systems to prompt healthcare professionals to identify the need for testing during appointments and offer it if needed.subhead:People who decline a testIf people choose not to take up the immediate offer of a test, tell them about nearby testing services and how to get self-sampling kits.subhead:Partners of people who test positivePartners of people who test positive should receive a prompt offer and recommendation of an HIV test through partner notification procedures.Quality standardsThe following quality statements are relevant to this part of the interactive flowchart.4Regular HIV testing5People who may have been exposed to HIVSourcesThe NICE guidance that was used to create this part of the interactive flowchart. NG60", "drug": {}}}, {"category": "treatment", "id": "t6022", "name": "delivering effective hiv testing services", "draggable": "true", "value": {"name": "delivering effective hiv testing services", "type": "information and support", "time": "", "intention": "", "description": "title:delivering effective hiv testing services", "drug": {}}}, {"category": "treatment", "id": "t6016", "name": "point of care testing and self sampling", "draggable": "true", "value": {"name": "point of care testing and self sampling", "type": "information and support", "time": "", "intention": "", "description": "title:point of care testing and self-samplinghead:Point of care testing and self-samplingsubhead:Point of care testingOffer POCT in situations where it would be difficult to give people their results, for example if they are unwilling to leave contact details.Explain to people at the time of their test about the specificity and sensitivity of the POCT being used and that confirmatory serological testing will be needed if the test is reactive.subhead:Self-sampling Consider providing self-sampling kits to people in groups and communities with a high rate of HIV (see establish local prevalence).Ensure that people know how to get their own self-sampling kits, for example, by providing details of websites to order them from.SourcesThe NICE guidance that was used to create this part of the interactive flowchart. NG60", "drug": {}}}]}